Trials / Completed
CompletedNCT04682288
Levofloxacin Ocular Implant for Ocular Surgery
An Interventional, Open Label, Non-randomized, Phase Ia Safety and Tolerability Study of Levofloxacin Ocular Implant in Subjects Undergoing Routine Cataract Surgery.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- PolyActiva Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi center, open label, interventional study in one eye of 5 subjects scheduled for uncomplicated cataract surgery with administration of a single Levofloxacin Ocular Implant in the posterior sulcus of the surgical eye at the end of cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levofloxacin Ocular Implant | Levofloxacin Ocular Implant an implant that delivers a bolus dose of levofloxacin and a constant daily dose for a further 5-7 days. |
Timeline
- Start date
- 2021-01-04
- Primary completion
- 2021-10-14
- Completion
- 2021-10-14
- First posted
- 2020-12-23
- Last updated
- 2021-12-08
Locations
3 sites across 2 countries: United States, Australia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04682288. Inclusion in this directory is not an endorsement.